Archive
  • Road to USP <800> Compliance: Section 10

    On the Road to Compliance, Sections 1 through 9 of USP Chapter 800: Hazardous Drugs—Handling in Healthcare Settings are the blueprint and engineering structures with checks and balances for quality control. They also provide direct protective measures on and …

  • Top leaders in pharmacy gather to address major issues facing IDNs in 2018

    Written by: Lynn Eschenbacher, PharmD, MBA, FASHP, Chief Pharmacy Officer, The Resource Group, James Jorgenson, RPh, MS, FASHP, Chief Executive Officer, Visante, Inc. & Cedric Terrell, PharmD, MHA, Senior Vice President, Pharmacy Services, Novant Health

    Visante’s Business of Pharmacy™ …

  • Edaravone: 1st New ALS Treatment Option in 25 Years

    Published in May 2018, the supplement to The American Journal of Managed Care® (available here), entitled “Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy—A Roundtable Discussion,” reviews the therapeutic spectrum for amyotrophic lateral sclerosis (ALS) …

  • 340B Regulatory and Legislative Update

    In the January 2018 Point of View, we discussed threats that the 340B Program is facing in 2018.

    We also provided an overview of changes that have already occurred, as well as identified new threats the 340B Program is …